Index Overview
Nifty MidSmall Healthcare
Return Overview
1M
-0.20%
3M
+9.29%
6M
+19.85%
1Y
+16.80%
3Y
+25.06%
5Y
+14.94%
10Y
+17.59%
Max
+17.66%
Fundamentals
| Asset Type | Equity |
| Index Type | Sectoral Index |
| No. of Companies | 30 Companies |
| Market Cap Focus | Mid & Small Cap |
| Std Deviation (1 yr) | 0.91% |
| P/E | 63.74 |
| P/B | 7.85 |
| Div Yield | 0.85% |
| Asset Type | Equity |
| Index Type | Sectoral Index |
| No. of Companies | 30 |
| Market Cap Focus | Mid & Small Cap |
| P/E | 63.74 |
| P/B | 7.85 |
| Div Yield | 0.85% |
| Std Deviation (1 yr) | 0.91% |
Exchange Traded Funds (ETFs)
No exchange traded funds (etfs) available for this index
Index Funds
| Fund Name | ||||||
|---|---|---|---|---|---|---|
| N/A | 182 | 0.40% | 0.09% | 0.49% | ||
| N/A | 40 | 0.54% | 0.09% | 0.63% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | All-In-Cost | Score |
|---|---|---|---|---|---|---|
| N/A | 182 | 0.40% | 0.09% | 0.49% | ||
| N/A | 40 | 0.54% | 0.09% | 0.63% |
Sectoral Allocation
Total
100%
allocation
- Healthcare98.6%
- Business Services1.4%
- Healthcare98.6%
- Business Services1.4%
Index Constituents
| Name | Weight |
|---|
| Lupin Ltd. | 9.2% |
| Laurus Labs Ltd. | 8.8% |
| Fortis Healthcare Ltd. | 8.1% |
| Aurobindo Pharma Ltd. | 6.6% |
| Glenmark Pharmaceuticals Ltd. | 5.7% |
| Alkem Laboratories Ltd. | 5.3% |
| Biocon Ltd. | 5.1% |
| Mankind Pharma Ltd. | 4.5% |
| Ipca Laboratories Ltd. | 3.5% |
| Krishna Institute of Medical Sciences Ltd | 3.1% |
| Aster DM Healthcare Ltd. | 3.1% |
| Gland Pharma Ltd. | 3.0% |
| JB Chemicals & Pharmaceuticals Ltd. | 3.0% |
| Wockhardt Ltd. | 2.8% |
| Sai Life Sciences Ltd. | 2.6% |
| Neuland Laboratories Ltd. | 2.4% |
| Abbott India Ltd. | 2.3% |
| Narayana Hrudayalaya Ltd. | 2.2% |
| Dr. Lal Pathlabs Ltd. | 2.1% |
| Ajanta Pharma Ltd. | 2.0% |
| Granules India Ltd. | 1.9% |
| Piramal Pharma Ltd. | 1.8% |
| Global Health Ltd. | 1.7% |
| Onesource Specialty Pharma Ltd. | 1.7% |
| Glaxosmithkline Pharmaceuticals Ltd. | 1.5% |
| Natco Pharma Ltd. | 1.5% |
| Syngene International Ltd. | 1.4% |
| Cohance Lifesciences Ltd. | 1.2% |
| Pfizer Ltd. | 1.2% |
| Poly Medicure Ltd. | 0.9% |
NameWeight
Lupin Ltd.9.2%
Laurus Labs Ltd.8.8%
Fortis Healthcare Ltd.8.1%
Aurobindo Pharma Ltd.6.6%
Glenmark Pharmaceuticals Ltd.5.7%
Alkem Laboratories Ltd.5.3%
Biocon Ltd.5.1%
Mankind Pharma Ltd.4.5%
Ipca Laboratories Ltd.3.5%
Krishna Institute of Medical Sciences Ltd3.1%
Aster DM Healthcare Ltd.3.1%
Gland Pharma Ltd.3.0%
JB Chemicals & Pharmaceuticals Ltd.3.0%
Wockhardt Ltd.2.8%
Sai Life Sciences Ltd.2.6%
Neuland Laboratories Ltd.2.4%
Abbott India Ltd.2.3%
Narayana Hrudayalaya Ltd.2.2%
Dr. Lal Pathlabs Ltd.2.1%
Ajanta Pharma Ltd.2.0%
Granules India Ltd.1.9%
Piramal Pharma Ltd.1.8%
Global Health Ltd.1.7%
Onesource Specialty Pharma Ltd.1.7%
Glaxosmithkline Pharmaceuticals Ltd.1.5%
Natco Pharma Ltd.1.5%
Syngene International Ltd.1.4%
Cohance Lifesciences Ltd.1.2%
Pfizer Ltd.1.2%
Poly Medicure Ltd.0.9%
Holdings Concentration
Total covered: 100%
Top 1–5
5 holdings
38.4%
38%
share
Top 6–10
5 holdings
21.6%
22%
share
Top 11–20
10 holdings
25.5%
25%
share
Beyond 20
10 holdings
14.6%
15%
share
Market Cap Classification
Total
100%
allocation
- Mid Cap64.5%
- Small Cap35.6%
- Mid Cap64.5%
- Small Cap35.6%
Index Methodology
| Factor Basis | Size (Market Cap), Sector/Theme |
| What universe selected from? | Nifty MidSmallcap 400 index |
| Weightage? | Periodic Capped Free Float Market Cap Weighting |
| Stocks Included | Maximum 30 companies. Top 30 mid &/or smallcap healthcare stocks based on six-month average free-float market capitalization are selected |
| Exclusions | Stocks Excluded from Nifty 500, Stocks not meeting criteria of top 30 based on Free Float market cap (Healthcare industry, Mid & Small Cap only); Non F&O Stocks hitting circuit limit in 20% of trading days over last 6months |
| Factor Basis | Size (Market Cap), Sector/Theme |
| Universe | Nifty MidSmallcap 400 index |
| Weightage | Periodic Capped Free Float Market Cap Weighting |
| Stocks Included | Maximum 30 companies. Top 30 mid &/or smallcap healthcare stocks based on six-month average free-float market capitalization are selected |
| Exclusions | Stocks Excluded from Nifty 500, Stocks not meeting criteria of top 30 based on Free Float market cap (Healthcare industry, Mid & Small Cap only); Non F&O Stocks hitting circuit limit in 20% of trading days over last 6months |
Index • Last updated: 11/09/2026
Note: Above data is based on average of ETFs / Index Funds.